First-in-class drugs for CRPC

MacKay, Simon (Principal Investigator)
Boyd, Marie (Co-investigator)
Paul, Andrew (Co-investigator)
Plevin, Robin (Co-investigator)
Suckling, Colin (Co-investigator)

Project: Research

Status	Finished
Effective start/end date	1/05/13 → 30/04/16

Funding

Prostate Cancer Charity: £249,289.00

Design and synthesis of novel aminoindazole-pyrrolo[2,3-b]pyridine inhibitors of IKKα that selectively perturb cellular non-canonical NF-κB signalling
Riley, C., Ammar, U., Alsfouk, A., Anthony, N. G., Baiget, J., Berretta, G., Breen, D., Huggan, J., Lawson, C., McIntosh, K., Plevin, R., Suckling, C. J., Young, L. C., Paul, A. & Mackay, S. P., 26 Jul 2024, In: Molecules. 29, 15, 29 p., 3515.
Research output: Contribution to journal › Article › peer-review

Open Access
File
10 Link opens in a new tab Citations (Scopus)

73 Downloads (Pure)